These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28246926)

  • 21. Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.
    Li X; Niu QT; Warmington KS; Asuncion FJ; Dwyer D; Grisanti M; Han CY; Stolina M; Eschenberg MJ; Kostenuik PJ; Simonet WS; Ominsky MS; Ke HZ
    Endocrinology; 2014 Dec; 155(12):4785-97. PubMed ID: 25259718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats.
    Ma YL; Hamang M; Lucchesi J; Bivi N; Zeng Q; Adrian MD; Raines SE; Li J; Kuhstoss SA; Obungu V; Bryant HU; Krishnan V
    Bone; 2017 Apr; 97():20-28. PubMed ID: 27939957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Sclerostin Depletion Stimulate Fracture Healing in a Mouse Model?
    Alzahrani MM; Rauch F; Hamdy RC
    Clin Orthop Relat Res; 2016 May; 474(5):1294-302. PubMed ID: 26608966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Romosozumab for the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Biol Ther; 2017 Feb; 17(2):255-263. PubMed ID: 28064540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trabecular plates and rods determine elastic modulus and yield strength of human trabecular bone.
    Wang J; Zhou B; Liu XS; Fields AJ; Sanyal A; Shi X; Adams M; Keaveny TM; Guo XE
    Bone; 2015 Mar; 72():71-80. PubMed ID: 25460571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micromechanical analyses of vertebral trabecular bone based on individual trabeculae segmentation of plates and rods.
    Liu XS; Bevill G; Keaveny TM; Sajda P; Guo XE
    J Biomech; 2009 Feb; 42(3):249-56. PubMed ID: 19101672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
    Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional morphometric properties of rod- and plate-like trabeculae in adolescent cancellous bone.
    Ding M; Lin X; Liu W
    J Orthop Translat; 2018 Jan; 12():26-35. PubMed ID: 29662776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic simulation of three dimensional architectural and mechanical alterations in human trabecular bone during menopause.
    Liu XS; Huang AH; Zhang XH; Sajda P; Ji B; Guo XE
    Bone; 2008 Aug; 43(2):292-301. PubMed ID: 18550463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct Tissue Mineral Density in Plate- and Rod-like Trabeculae of Human Trabecular Bone.
    Wang J; Kazakia GJ; Zhou B; Shi XT; Guo XE
    J Bone Miner Res; 2015 Sep; 30(9):1641-50. PubMed ID: 25736715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse.
    Zhang D; Hu M; Chu T; Lin L; Wang J; Li X; Ke HZ; Qin YX
    Bone; 2016 Jun; 87():161-8. PubMed ID: 26868528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent- and Tissue-Level Yield Behaviors of L4 Vertebral Trabecular Bone and Their Associations with Microarchitectures.
    Gong H; Wang L; Fan Y; Zhang M; Qin L
    Ann Biomed Eng; 2016 Apr; 44(4):1204-23. PubMed ID: 26104807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
    Saag KG; Petersen J; Brandi ML; Karaplis AC; Lorentzon M; Thomas T; Maddox J; Fan M; Meisner PD; Grauer A
    N Engl J Med; 2017 Oct; 377(15):1417-1427. PubMed ID: 28892457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.
    Zhang Y; Wang L; Song Y; Zhao X; Wong MS; Zhang W
    Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass.
    Keaveny TM; Crittenden DB; Bolognese MA; Genant HK; Engelke K; Oliveri B; Brown JP; Langdahl BL; Yan C; Grauer A; Libanati C
    J Bone Miner Res; 2017 Sep; 32(9):1956-1962. PubMed ID: 28543940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
    Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
    Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contributions of trabecular rods of various orientations in determining the elastic properties of human vertebral trabecular bone.
    Liu XS; Zhang XH; Guo XE
    Bone; 2009 Aug; 45(2):158-63. PubMed ID: 19379849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures.
    Rozental TD; Johannesdottir F; Kempland KC; Bouxsein ML
    Osteoporos Int; 2018 Feb; 29(2):409-419. PubMed ID: 29101409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
    Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
    Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.